Request Demo!

Press Releases

ZoomMed sells certain intellectual property rights in its ZRx Prescriber to KDA Group Inc., in exchange of 20,000,000 shares of KDA Group valued at $ 3,140,000

Brossard, May 11, 2021 — ZoomMed Inc. (the “Corporation” or “ZoomMed”) (TSX Venture  Exchange:ZMD) is proud to announce that the transaction to acquire the intellectual property rights  of the ZRx Prescriber to develop, market and operate the ZRx Prescriber in the United States,  Europe and the United Kingdom has been completed with the wholly owned…

Read More

ZoomMed and KDA Group join forces to distribute the ZRx Prescriber in the United States

Montreal, May 31, 2018 – ZoomMed Inc. (the “Corporation” or “ZoomMed”) (TSX Venture Exchange: ZMD) and KDA Group Inc. (“KDA”) (TSX Venture Exchange: KDA), are proud to announce an agreement whereby KDA Group could distribute under a non-exclusive license the ZRx Prescriber, develop by ZoomMed, in the United States. The Corporation and KDA Group are…

Read More

ZoomMed closes the sale to Familiprix for $2,000,000 of its ownership rights of “PraxisLab”

Montreal, November 19, 2015 – ZoomMed Inc. (TSX : ZMD) announces that it has closed the sale of all of its ownership of intellectual property rights of “PraxisLab” to Familiprix inc. for a cash consideration of $2,000,000. Already in November 2013, Familiprix had previously acquired a limited ownership of the intellectual property rights of “PraxisLab”…

Read More

ZoomMed obtains the american distribution rights of Rx Vigilance “Quick Glance”

Montreal, November 19, 2015 – ZoomMed Inc. (TSX : ZMD) is proud to announce that it has entered into an agreement with Vigilance Santé Inc. for the distribution rights, in the American market, of their widely acclaimed therapeutic advisor, the Rx Vigilance “Quick Glance”. Rx Vigilance “Quick Glance” is one of the cornerstone elements in…

Read More

ZMD sells interest in its ZRx Prescriber for up to $6,800,000.

ZoomMed to focus on U.S. market by selling to TELUS Health an interest in its ZRx Prescriber Technology and related Canadian operations   Montreal, September 3, 2014 – ZoomMed Inc. (TSX-V: ZMD) – ZoomMed has sold an interest in the technology underlying its ZRx Prescriber Technology and certain related Canadian operations to TELUS Health for up…

Read More

ZoomMed signs an agreement with Desjardins Insurance DSF

Montreal, February 17, 2014 – ZoomMed Inc. (TSX-V: ZMD) (the “Company” or “ZoomMed”) is pleased to announce that it has signed an agreement with Desjardins Insurance for the development and operation of a project focusing for a web-based solution to integrate selected insurance plan information into the ZRx Prescriber to provide physician users with information…

Read More